Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2024Medical Cannabis and CannabinoidsOpen Access

Long-term treatment for unspecified anxiety disorders with cannabidiol (CBD): A retrospective case series from real-world evidence (RWE) in Colombia

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJuan F. Gálvez‐FlórezHGHernan Felipe Guillén-BurgosCFCamilo A Flórez-Puentes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gálvez‐Flórez et al. (2024) studied this question.

synapsesocial.com/papers/68e5891fb6db643587524dc4https://doi.org/10.1159/000539754
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study2025
  2. 2Efficacy and Safety of Cannabidiol for Anxiety: A Bibliometric Analysis and Systematic Review2025
  3. 3Improved Migraine Disability, Sleep Quality, and Well-Being in Individuals with Chronic Migraine2026
  4. 4Treatment of neuropsychiatric symptoms in Alzheimer’s disease with a cannabis-based magistral formulation: An open-label prospective cohort study2024 · 2 citations
  5. 50394 The CANnabidiol Use for RElief of Short-Term Insomnia (CAN-REST). a Randomised Placebo-Controlled Clinical Trial2024 · 2 citations